Register before April 19th and Save. Click here to register now!
Blood Pressure Targets and the Impact of the Clinical Trial Scientific Sessions will present the latest science in:
- Resistant Hypertension
- Device Treatment of Hypertension
- Non-Invasive Treatment of Hypertension
- Innovations in Diagnosis and Treatment
- Blood Pressure and Vascular Function
- Within Class Differences in Antihypertensive Therapies
The 2013 Annual Scientific meeting topics are organized around three (3) concurrent themes:
Translational Issues in Hypertension, Therapy of Hypertension and Pathobiology of Hypertension. The Scientific Sessions feature several innovative components designed to enhance the translation of basic and applied research into effective hypertension prevention and treatment strategies.
Hypertension Highlights 2013 – Wednesday, May 15, 2013 Hypertension Highlights is a full-day program dedicated to educating clinicians and scientists about some of the most interesting, controversial and evolving topics in the field. The program will include state-of-the-art presentations on Hypertension and the Brain, Obesity and Cardiometabolic Diseases and Modulators of Blood Pressure and Vascular Function. It is an ideal update for Hypertension Specialists and those wishing to become specialists in the field.
Plenary Session I – Thursday, May 16, 2013 The
Keynote speaker for the opening session will be Thomas Fleming, PhD, Professor and Chair, Biostatics, University of Washington, Seattle, WA. Dr. Fleming will speak about the “Successes and Pitfalls of Primary and Secondary Prevention Trial Data in Hypertension and Vascular Diseases.” Following Dr. Fleming’s lecture will be Daniel B. Mark, MD, MPH, Professor of Medicine, Vice Chief for Academic Affairs, Division of Cardiology, Department of Medicine at Duke University Medical Center, Durham, NC and Editor, American Heart Journal, presenting a lecture on “The Importance of Studying Cost-effectiveness and Use of Medical Resources within the Trial.” William C. Cushman, MD, Professor of Preventive Medicine and Medicine at the University of Tennessee College of Medicine in Memphis and Chief, Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN will present a lecture entitled “What is the Rationale and Importance of SPRINT When We Have the Results of ACCORD?” Dr. David J. Magid, MD, MPH, Associate Professor of Medicine, University of Colorado Health Sciences Center and Director of Research – Colorado Permanente Medical Group, will address the topic of “Outcomes in Cardiovascular Clinical Research: The Patient-Centered Approach.”
Plenary Session II – Friday, May 17, 2013 The ASH Distinguished Scientist Award, Young Scholar Award and Marvin Moser Clinical Hypertension Award will be presented in Plenary Session II – the ASH Awards Session.
Special Session on How to Use the NUCC Taxonomy Code to your Advantage – Friday, May 17, 2013 This session will provide information important to your practice on how to understand and use the National Uniform Claim Committee Hypertension Specialist Taxonomy Code. Nancy Spector, BSN, MSC, Director, Electronic Medical Systems, American Medical Association, Chicago, IL and Gail S. Kocher, MPA, NUCC Code Subcommittee Co-Chair, Chicago, IL will participate in a panel discussion moderated by George L. Bakris, MD on proper use and billing as a Hypertension Specialist.
Young Investigator-in-Training Abstract Competition – Wednesday, May 15, 2013 Trainees submitting the highest ranking abstracts to the meeting will present their work orally in a special session and compete for cash prizes. This highlighted session is consistent with ASH’s goal to foster and facilitate the training of young and new investigators in hypertension.
Hypertension for the Primary Care Clinician – Fri. May 17 & Sat. May 18, 2013 This program will address commonplace questions that face clinicians in day-to-day care of hypertension including hypertension management, special populations, home and ambulatory blood pressure monitoring and the practical application of guidelines.
Debates – Thursday, May 16 and Friday, May 17, 2013 This year there are several debates on controversial topics of relevance to Hypertension Specialists.
Joint Society Sessions Educational sessions resulting from the partnership with other societies, both national and international (e.g., AHA, ACC, ASN, and ESH to name a few), focused on the topic of hypertension and cardiovascular disease will enhance and broaden the scope of the ASH 2013 Meeting.
New This Year – Joint Meetings with ISHIB ASH and the International Society on Hypertension in Blacks (ISHIB) have forged an agreement to convene our annual conferences in May 2013 in San Francisco, with the ISHIB program to overlap with the 2013 ASH Annual Scientific Meeting. The collaboration will benefit both societies in supporting our similar goals of improving the treatment of hypertension and advancing knowledge related to the disease; affording sponsors and attendees the convenience of taking in two meetings while only arranging travel to a single location. The societies believe that the extended education and exposure to members and sponsors, respectively, will establish added value for all participants that plan to attend both meetings.
Sponsored Satellite Symposia and Exhibits The Society will also sponsor a industry-supported Satellite Symposia which will introduce novel approaches to antihypertensive and device therapies. The ASH Hypertension Resource Pavilion will host many informative scientific, technical, periodical and book exhibits designed to support you in your mission of providing the latest in care for your hypertensive patients.
Register before April 19th and Save. Click here to register now!
Click here to view the Program & Registration Brochure.
No comments:
Post a Comment
Keep a civil tongue.